What do systematic reviews say?

Intervention not reported

The intervention showed no clear difference in death on induction therapy (moderate certainty).

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  RR 1.1 [0.88, 1.38]
  5 studies · 2055 participants
  Moderate

Intervention not reported

The intervention showed no clear difference in death on induction therapy (moderate certainty).

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  RR 0.75 [0.5, 1.13]
  2 studies · 964 participants
  Moderate

Intervention not reported

The intervention probably leads to higher death on induction therapy (moderate certainty).

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  RR 1.18 [1.01, 1.36]
  14 studies · 6349 participants
  Moderate

Intervention not reported

• The effects of idarubicin versus other anthracyclines for induction therapy of patients with newly diagnosed leukaemia 2015 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported